Purchased the Boehringer Ingelheim' s CFC MDI production plant in Taiwan at 2006, Synmosa Biopharma has set up a research team.The most advance equipment requested were purchased and up to date international inhalation product developing guidelines, such as EMEA and FDA guidelines, were followed in order to develop good quality HFA MDIs. With self-developed low ethanol content formulation, Intech Biopharm's HFA MDIs exhibit pr...
Purchased the Boehringer Ingelheim' s CFC MDI production plant in Taiwan at 2006, Synmosa Biopharma has set up a research team.The most advance equipment requested were purchased and up to date international inhalation product developing guidelines, such as EMEA and FDA guidelines, were followed in order to develop good quality HFA MDIs. With self-developed low ethanol content formulation, Intech Biopharm's HFA MDIs exhibit profiles with excellent delivered dose uniformity, desired fine particle size distribution and less physical burden to the patients.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.